Gedeon Richter Deal History & Licensing Activity
Gedeon Richter is a large pharma headquartered in Hungary. Over the past three years, Gedeon Richter has been involved in 4 licensing and acquisition transactions, with a primary focus on Antibodies (3 deals). The company currently has 3 active clinical trials, primarily in Other.
Deals (12mo)
2
Active Trials
3
Top Modality
Antibodies
Focus Area
Other
Gedeon Richter Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Gedeon Richter in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Lenzetto | Gedeon Richter Plc | Small Molecules | Approved | license | May 28, 2026 |
| FMC2 | FimmCyte AG | Antibodies | Preclinical | option | Feb 18, 2026 |
Gedeon Richter Pipeline Focus
Therapeutic areas and modalities where Gedeon Richter is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Gedeon Richter Strategic Signals
Key indicators of Gedeon Richter's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Patent Cliffs
- Undisclosed—
Strategic Profile
Acquisition Appetite
Strategic Priorities
Gedeon Richter Clinical Pipeline
Gedeon Richter has 3 active clinical trials across 3 development phases.
1
Phase 1
1
Phase 2
1
Phase 3
See How Your Asset Matches Gedeon Richter's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Gedeon Richter Licensing & Deal Activity
Gedeon Richter is a large pharma company based in Hungary that has been actively engaged in licensing transactions across the biopharma landscape. With 4 deals over the past three years, Gedeon Richter ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Gedeon Richter include Other (2 deals and trials), Women's Health (2 deals and trials), Neurology (1 deal and trial), and Immunology (1 deal and trial). In terms of modality, Gedeon Richter has shown particular interest in antibodies, small molecules, small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Gedeon Richter and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Gedeon Richter's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.